In relation to the clinicopathological parameters of CRC, it was reported previously that the PIV was a good marker that aligned with clinical stage [37], and age ≥ 65 years, distant metastases, KRAS wild type, and deficiency in DNA mismatch repair were associated with higher PIVs [38]. Here, KRAS is linked to colorectal carcinoma.